Australian University Rankings Guide

Journal of Neuro-Ophthalmology (ERA Journal)

Journal of Neuro-Ophthalmology is an ERA accredited research journal used as part of the evaluation of the ERA research rankings.

Journal of Neuro-Ophthalmology issns are issn1: 1070-8022 issn2: 1536-5166.

The fields covered by Journal of Neuro-Ophthalmology as part of the evaluation of Australian university research excellence are:

Clinical Sciences Research Rankings (Sub-Field)

Neurosciences Research Rankings (Sub-Field)

Ophthalmology and Optometry Research Rankings (Sub-Field)

Other ERA-accredited journals supporting the evaluation of the Clinical Sciences field include:

- Aktuality v Nefrologii
- Blood Coagulation and Fibrinolysis: international journal in haemostasis and thrombosis
- Emergency Medicine Australasia
- European Archives of Psychiatry and Clinical Neuroscience: official organ of the German society for biological psychiatry
- Fatigue: Biomedicine Health and Behavior
- Fuss and Sprunggelenk: German journal of foot and ankle surgery
- Journal of Manipulative and Physiological Therapeutics
- Journal of Speech Language and Hearing Research
- Maandblad Geestelijke Volksgezondheid (MGV)
- Neurodegenerative Diseases
- ORL: Journal for Oto-Rhino-Laryngology Head and Neck Surgery
- Ophthalmology
- Psychodynamic Practice: individuals groups and organisations
- Radiologic Clinics of North America
- Rhinology

ERA Research Rankings Submenu

- ERA 2018 Outcomes Research Rankings List

- ERA 2018 Research Rankings Analysis

- ERA 2018 Individual University Outcomes List

- ERA List of Research Fields Rankings

- ERA Journal Rankings 2018 List

Latest News and Updates:

- Top 10 Best Australian Universities

- Gender Balance Male-Female Ratio

- ERA 2018 Outcomes Research Rankings List

- University Bachelor Degree Completion Rates

- QS Employability Rankings Australian Universities

- ARWU World Rankings of Australian Universities

- Group of Eight (go8) World Rankings

Share This Page

  • Share on Facebook1
  • Share on Twitter2
  • Share on Linkedin3
  • Share on Reddit4